| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/02/2011 | US7989622 Phosphatidylinositol 3-kinase inhibitors and methods of their use |
| 08/02/2011 | US7989620 Hydantoin derivatives for the treatment of obstructive airway diseases |
| 08/02/2011 | US7989602 Synthetic molecules having immune activity |
| 08/02/2011 | US7989601 Heterobifunctional pan-selectin inhibitors |
| 08/02/2011 | US7989503 Smooth muscle peristole inhibitor |
| 08/02/2011 | US7989502 Intranasal delivery of modafinil |
| 08/02/2011 | US7989501 Treating renal cancer using a 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde |
| 08/02/2011 | US7989500 Synthesis, methods of using, and compositions of cycloalkylmethylamines |
| 08/02/2011 | US7989499 Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase |
| 08/02/2011 | US7989498 Inhibitors of IMPDH enzyme |
| 08/02/2011 | US7989497 Squaramide derivatives as CXCR2 antagonist |
| 08/02/2011 | US7989496 Transdermal delivery of ketoprofen polar derivatives |
| 08/02/2011 | US7989495 Compositions and methods for inhibiting NF-κB mediated tumorigenicity and adhesion dependent survival of cancer cells |
| 08/02/2011 | US7989494 Polymorphs of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide |
| 08/02/2011 | US7989493 Natural vitamin E compositions with superior antioxidant potency |
| 08/02/2011 | US7989492 Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidant activity |
| 08/02/2011 | US7989491 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 08/02/2011 | US7989490 Injectable formulations of taxanes for cad treatment |
| 08/02/2011 | US7989489 Synergistic mixtures |
| 08/02/2011 | US7989488 Compositions and methods for storing holographic data |
| 08/02/2011 | US7989487 Estrogen receptor modulators and uses thereof |
| 08/02/2011 | US7989486 In combination with epidermal growth factor receptor tyrosine kinase inhibitors; apoptosis of infected cells; suppressing formation of post infectious chronic inflammatory conditions; human and veterinary medicine |
| 08/02/2011 | US7989485 Imidazole compounds having pharmaceutical activity towards the sigma receptor |
| 08/02/2011 | US7989484 Dual-acting antihypertensive agents |
| 08/02/2011 | US7989483 4-heteroarylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof |
| 08/02/2011 | US7989482 Indoline anti-cancer agents |
| 08/02/2011 | US7989481 Indane derivatives as modulators of ion channels |
| 08/02/2011 | US7989480 Aryl amino acid derivatives as inhibitors for treating inflammation |
| 08/02/2011 | US7989479 Use of a p38 kinase inhibitor for treating psychiatric disorders |
| 08/02/2011 | US7989478 Cinnamoyl compound and use of the same |
| 08/02/2011 | US7989477 Monocyclic heterocycles as kinase inhibitors |
| 08/02/2011 | US7989475 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 08/02/2011 | US7989474 Use of Lck inhibitors for treatment of immunologic diseases |
| 08/02/2011 | US7989473 Stable laquinimod preparations |
| 08/02/2011 | US7989472 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 08/02/2011 | US7989471 Macrocyclic inhibitors of hepatitis C virus |
| 08/02/2011 | US7989470 3,8-substituted 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/02/2011 | US7989469 Certain chemical entities, compositions, and methods |
| 08/02/2011 | US7989468 Administering 1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazoyl)-1,8-naphthyridine-3-carboxylic acid as anticarcinogenic agent |
| 08/02/2011 | US7989467 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process |
| 08/02/2011 | US7989466 Methods to inhibit or augment an inflammatory response |
| 08/02/2011 | US7989465 4,6-disubstituted pyrimidines useful as kinase inhibitors |
| 08/02/2011 | US7989464 mGluR1 antagonists as therapeutic agents |
| 08/02/2011 | US7989463 Biccyclic compounds as GATA modulators |
| 08/02/2011 | US7989462 4-arylamin-or-4-heteroarylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2011 | US7989461 Substituted quinazolinamine compounds for the treatment of cancer |
| 08/02/2011 | US7989460 Quinazoline derivatives as angiogenesis inhibitors |
| 08/02/2011 | US7989459 Purinones and 1H-imidazopyridinones as PKC-theta inhibitors |
| 08/02/2011 | US7989457 Used to treat diabetic and other glucagon related metabolic disorders such as obesity, hyperglycemia, atherosclerosis, ischemic heart disease, stroke, neuropathy, and wound healing; (R,S)-Methanesulfonic acid 2-(3-methyl-4'-trifluoromethyl-biphenyl-4-yl)-propyl ester |
| 08/02/2011 | US7989456 Pyrazine kinase inhibitors |
| 08/02/2011 | US7989455 Compounds, compositions and methods |
| 08/02/2011 | US7989454 Leukotriene B4 inhibitors |
| 08/02/2011 | US7989453 Antitumor agents; for example, N-(2-methyl-6-quinolyl)-[1-(4-chlorobenzyl)indole-3-yl]glyoxylamide |
| 08/02/2011 | US7989452 Sterile injectible solution of drug in solvent or diluent |
| 08/02/2011 | US7989451 Tricyclic 1,2,4-triazine oxides and compositions for therapeutic use in cancer treatments |
| 08/02/2011 | US7989450 Functionalized diarylisoxazoles inhibitors of ciclooxygenase |
| 08/02/2011 | US7989449 4,5-dihydro-oxazol-2-yl amine derivatives |
| 08/02/2011 | US7989448 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 08/02/2011 | US7989447 1,5 and 3,6-substituted indole compounds having NOS inhibitory activity |
| 08/02/2011 | US7989446 4-amino 5-cyanopyrimidine derivatives |
| 08/02/2011 | US7989445 Thienopyrimidone compound |
| 08/02/2011 | US7989444 Compounds having affinity for dopamine D3 receptor and uses thereof |
| 08/02/2011 | US7989442 (cis)-8-fluorodibenzo[b,f]pyrido[1,2-d]oxazepine-1-amine derivatives; contraception, hormone replacement therapy (HRT) or gynaecological disorders, adjuvant therapy in cancer |
| 08/02/2011 | US7989441 Organic compounds |
| 08/02/2011 | US7989440 Metal coordinated compositions |
| 08/02/2011 | US7989439 Substituted pyrazoles, compositions containing these, method of production and use |
| 08/02/2011 | US7989438 Therapeutic compounds |
| 08/02/2011 | US7989436 Estrogenic compounds and pharmaceutical formulations comprising the same |
| 08/02/2011 | US7989435 Phytic citrate compounds and process for preparing the same |
| 08/02/2011 | US7989434 Heterocyclic self-immolative linkers and conjugates |
| 08/02/2011 | US7989433 Substituted thieno[3,2-D]pyrimidines as melanin concentrating hormone receptor-1 antagonists |
| 08/02/2011 | US7989432 Micelles |
| 08/02/2011 | US7989431 4-{3-[6-Amino-9-(5-cyclopropylcarbamoyl-3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-cyclohexanecarboxylic acid methyl ester; for inflammation, such as organ, tissue or cell transplantation, angioplasty (PCTA), inflammation following ischemia/reperfusion, or grafting |
| 08/02/2011 | US7989430 Antibacterial agents |
| 08/02/2011 | US7989424 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 08/02/2011 | US7989423 6″-amino-6″-deoxygalactosylceramides |
| 08/02/2011 | US7989422 Antibacterial agents |
| 08/02/2011 | US7989421 Use of dimiracetam in the treatment of chronic pain |
| 08/02/2011 | US7989420 Smooth muscle relaxation |
| 08/02/2011 | US7989195 Heterotrophic algal high cell density production method and system |
| 08/02/2011 | US7989182 Nucleic acid encoding SCN1A variant |
| 08/02/2011 | US7989007 Weight loss composition |
| 08/02/2011 | US7989006 Annatto extract compositions, including geranyl geraniols and methods of use |
| 08/02/2011 | US7989005 Heating rice bran oil under reduced pressure, adding a filler and then corosolic acid, cooling, encapsulating into a soft gel capsule |
| 08/02/2011 | US7989003 Method and composition for delivering zinc to the nasal membrane |
| 08/02/2011 | US7988999 Drug with enteric coating; oral administering |
| 08/02/2011 | US7988997 Matrix of water soluble polymer; solidificated foam |
| 08/02/2011 | US7988993 Oral controlled release dosage form |
| 08/02/2011 | US7988991 Adhesive patch |
| 08/02/2011 | US7988989 Nutritional product for enhancing growth and/or strengthening the immune system of equine foals |
| 08/02/2011 | US7988965 Methods of treating systemic lupus erythematosus with an antibody against costimulatory signal transduction molecule ailim |
| 08/02/2011 | US7988956 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 08/02/2011 | US7988952 Condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns |
| 08/02/2011 | CA2713292C Delayed release rasagiline formulation |
| 08/02/2011 | CA2668311C Enhancing photodamage caused by ultraviolet light using a 3-hydroxypyridine analog |
| 08/02/2011 | CA2667966C Pyrazoline compounds as mineralocorticoid receptor antagonists |
| 08/02/2011 | CA2655485C Penem prodrugs |
| 08/02/2011 | CA2620313C Nutritional method for elderly people |
| 08/02/2011 | CA2608890C Heterobicyclic metalloprotease inhibitors |
| 08/02/2011 | CA2608837C Sulfonamide derivatives useful as liver carnitine palmitoyl transferase (l-cpt1) inhibitors |